References
- Kimmel D W, Schutt A J. Multifocal leukoencephalopathy: Occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc 1993; 68: 363–365
- Hook C C, Kimmel D W, Krols L K, et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992; 31: 262–267
- Weiss H D, Walker M D, Wiernik P H. Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med 1974; 291: 75–81
- Greenwald E S. Organic mental changes with fluorouracil therapy. JAMA 1976; 235: 248–249
- Lynch H T, Proszcz C P, Albano W A, Lynch J F. Organic brain syndrome secondary to 5-fluorouracil toxicity. Dis Colon Rectum 1981; 24: 130–131
- Kuzahara S, Ohkoshi N, Kanemaru K, et al. Subacute leukoen-cephalopathy induced by carmofur, a 5-fluorouracil derivative. J Neurol 1987; 234: 365–370
- Okeda R, Karakama T, Kimura S, Toizumi S, Mithushima T, Yokoyama Y. Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs. Acta Neuropathol (Berl) 1984; 63: 334–343
- Koenig H K, Patel A. Biochemical basis for fluorouracil neurotoxicity: The role of Kreb's cycle inhibition by fluoroacetate. Arch Neurol 1970; 23: 155–160
- Hunan Medical University. Analysis of 10 subjects with encephalopathy due to levamisole. Bull Hunan Med Univ 1989; 14(1)1–6
- Vandervelde M, Boring J G, Hoff E J, Gingerich D A. The effect of levamisole on the canine central nervous system. J Neuropathol Exp Neurol 1978; 37: 165–173